Moreover, several studies have shown that targeting CD11a/CD18 or CD11b/CD18 reduces infiltration of leukocytes in the lung in models of endotoxemia (Basit et al., 2006) and sepsis (Asaduzzaman et al., 2008). This evidence concerns the gene ITGAM and Sepsis.